Quadrivalent Influenza Virus Split Vaccine (Shanghai Institute of Biological Products)

四价流感病毒裂解疫苗（上海生物制品研究所）

Report date: 2026/05/13 20:02:10

Base Information

Drug NameQuadrivalent Influenza Virus Split Vaccine (Shanghai Institute of Biological Products)
Drug Alias NameTetravalent influenza vaccine (Shanghai Institute of Biological Products)
ClassificationVaccines > Biological material > Viral vaccineVaccines > Application > Prophylactic vaccineVaccines > Vaccine type > Multivalent vaccine +[4] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsInfluenza A virus infectionsInfluenza, HumanInfluenza B virus infection
Global Approved IndicationsInfluenza, Human
Approved Indications in ChinaInfluenza, Human
Original Approved Country/TerritoryMainland China
Original Approved Date2021/03/02
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesShanghai Institute of Biological Products Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesInstitute Of Medical Biology, Chinese Academy Of Medical SciencesShanghai Institute of Biological Products Co Ltd
Inactive CompaniesN/A
Active IndicationsInfluenza A virus infectionsInfluenza, HumanInfluenza B virus infection
Inactive IndicationsN/A

Other Information

ATC CodeJ07BB02
Related LinksN/A